CVR: 38495712
Previous names: Asarina Danmark ApS
DKK -365,453
Gross profit
Net result: DKK -1,333,232
No owners listed
CVR · view ownership and management
Director role ended: Jakob Dynnes Hansen
CVR · 30/06/2026
View the full event history
Asarina Pharma ApS was a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Asarina Danmark ApS. The company has 3 employees (2018). In 2024, the company reported a gross profit of DKK -365,453 and a net result of DKK -1,333,232 compared with DKK -42,903,193 the year before. Equity in the 2024 report amounted to DKK -107,343.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | -365 t. | -1.3 mio. | 1.6 mio. | -107 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | -884 t. | -42.9 mio. | 2.5 mio. | 1.2 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | -509 t. | -9.8 mio. | 43.6 mio. | 42.7 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | -887 t. | -24.7 mio. | 50.7 mio. | 49 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | -1.9 mio. | -51.5 mio. | 61.6 mio. | 44.1 mio. | 2 | |
| 201901/01/2019 – 31/12/2019 | -1.4 mio. | -52.4 mio. | 63.8 mio. | 51.1 mio. | 3 | |
| 201801/01/2018 – 31/12/2018 | -891.9 mio. | -31.3 mia. | 59.5 mia. | 12.1 mia. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. Asarina Pharma ApS is registered in the Danish CVR register with the status Dissolved.
Asarina Pharma ApS was founded on 16 March 2017.
Asarina Pharma ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Asarina Pharma ApS had 3 employees in 2018 according to the Danish CVR register.
In 2024, Asarina Pharma ApS reported a gross profit of DKK -365,453.
Asarina Pharma ApS was located at c/o Jakob Dynnes Hansen, Prinsesse Alexandrines Alle 12 3. tv, 2920 Charlottenlund.
Asarina Pharma ApS was dissolved on July 22, 2026.
As of June 30, 2026, Jakob Dynnes Hansen has stepped down as liquidator of Asarina Pharma ApS.
On June 30, 2026, Asarina Pharma ApS exited liquidation.
As of September 15, 2025, Jakob Dynnes Hansen has left the board of directors of Asarina Pharma ApS.
As of September 15, 2025, Peter Hviid Nordkild has left the board of directors of Asarina Pharma ApS.
As of September 15, 2025, Jakob Dynnes Hansen is registered as liquidator of Asarina Pharma ApS.
As of September 15, 2025, Peter Hviid Nordkild has stepped down as adm. dir. of Asarina Pharma ApS.
As of September 15, 2025, Paul Karl Mikael de Potocki has stepped down as chairman of Asarina Pharma ApS.
On September 15, 2025, Asarina Pharma ApS entered liquidation.
Asarina Pharma ApS has published its annual report for 2024. Gross profit came to DKK -365,453, and the net result was DKK -1,333,232.
Asarina Pharma ApS has published its annual report for 2023. Gross profit came to DKK -884,336, and the net result was DKK -42,903,193.
As of July 10, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Asarina Pharma ApS.
Asarina Pharma ApS has published its annual report for 2022. Gross profit came to DKK -508,850, and the net result was DKK -9,822,821.
Asarina Pharma ApS has published its annual report for 2021. Gross profit came to DKK -887,274, and the net result was DKK -24,704,716.
Asarina Pharma ApS has published its annual report for 2020. Gross profit came to DKK -1,890,785, and the net result was DKK -51,528,246.
Asarina Pharma ApS has published its annual report for 2019. Gross profit came to DKK -1,446,125, and the net result was DKK -52,387,015.
Asarina Pharma ApS has published its annual report for 2018. Gross profit came to DKK -891,919,000, and the net result was DKK -31,279,340,000.
Asarina Pharma ApS has published its interim report for the period March 16, 2017 – December 31, 2017.
As of May 28, 2018, Jakob Dynnes Hansen has joined the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Peter Hviid Nordkild has joined the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Miroslav Reljanovic has left the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Claude Thierry Laugel has left the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Erik Graham Fagg has left the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Sten Gunnar Otto Skolling has left the board of directors of Asarina Pharma ApS.
As of May 28, 2018, Paul Karl Mikael de Potocki is registered as chairman of Asarina Pharma ApS.
As of May 28, 2018, Ola Gösta Flink has stepped down as chairman of Asarina Pharma ApS.
As of March 27, 2017, Sten Gunnar Otto Skolling has joined the board of directors of Asarina Pharma ApS.
On March 27, 2017, the company changed its name from Asarina Danmark ApS to Asarina Pharma ApS.
As of March 16, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Asarina Pharma ApS.
As of March 16, 2017, Miroslav Reljanovic has joined the board of directors of Asarina Pharma ApS.
As of March 16, 2017, Claude Thierry Laugel has joined the board of directors of Asarina Pharma ApS.
As of March 16, 2017, Erik Graham Fagg has joined the board of directors of Asarina Pharma ApS.
As of March 16, 2017, Peter Hviid Nordkild is registered as adm. dir. of Asarina Pharma ApS.
As of March 16, 2017, Ola Gösta Flink is registered as chairman of Asarina Pharma ApS.
Asarina Pharma ApS was founded on March 16, 2017.
Companies in the same industry and area
CVR 33992890
CVR 39297116
CVR 34626561
CVR 46299671
CVR 41120681
